Maternus-Kliniken AG (HAM:MAK) Forward Dividend Yield %: 0.00% (As of Jun. 27, 2026)


HAM:MAK Maternus-Kliniken AG HAM:MAK
41 GF Score
Price €0.97
GF Value €1.72
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Maternus-Kliniken AG Forward Dividend Yield %?

Maternus-Kliniken AG HAM:MAK +5.43% 41 Forward Dividend Yield % is 0.00% as of Jun. 27, 2026. GuruFocus rates HAM:MAK with a GF Score™ of 41/100 and a GF Value™ of €1.72 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 275 Healthcare Providers & Services companies, Maternus-Kliniken AG ranks worse than 363636% on this metric.

As of today (2026-06-27), the Forward Annual Dividend Yield of Maternus-Kliniken AG is 0.00%.

As of today (2026-06-27), the Trailing Annual Dividend Yield of Maternus-Kliniken AG is 0.00%.

HAM:MAK's Forward Dividend Yield % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.48
* Ranked among companies with meaningful Forward Dividend Yield % only.

Maternus-Kliniken AG's Dividends per Share for the six months ended in Dec. 2025 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Maternus-Kliniken AG  (HAM:MAK) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Maternus-Kliniken AG Forward Dividend Yield % Related Terms


HAM:MAK vs HCA, THC, DVA: Forward Dividend Yield % Comparison

For the Medical Care Facilities subindustry, Maternus-Kliniken AG's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Maternus-Kliniken AG Forward Dividend Yield % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Maternus-Kliniken AG's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Maternus-Kliniken AG's Forward Dividend Yield % falls into.


HAM:MAK
41GF Score
Maternus-Kliniken AG HAM:MAK
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maternus-Kliniken AG Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Maternus-Kliniken AG (HAM:MAK) has a Forward Dividend Yield % of 0.00% as of Jun. 27, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Maternus-Kliniken AG and its competitors. According to the industry distribution chart, Maternus-Kliniken AG ranks #999999 out of 275 companies in the Healthcare Providers & Services industry.
Is Maternus-Kliniken AG's Forward Dividend Yield % too high?
Maternus-Kliniken AG's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Maternus-Kliniken AG ranks #999999 out of 275 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Maternus-Kliniken AG has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Maternus-Kliniken AG's Forward Dividend Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Maternus-Kliniken AG ranks #999999 out of 275 companies for Forward Dividend Yield %. This places Maternus-Kliniken AG in the lower half of its industry. The industry median Forward Dividend Yield % is 2.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Healthcare Providers & Services company?
The median Forward Dividend Yield % among Healthcare Providers & Services companies is 2.48, based on 275 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Maternus-Kliniken AG and its competitors. For the Healthcare Providers & Services industry, the median Forward Dividend Yield % is 2.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maternus-Kliniken AG's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maternus-Kliniken AG stock overvalued right now?
Based on GuruFocus' analysis, Maternus-Kliniken AG (HAM:MAK) is currently considered Possible Value Trap. The stock's GF Value™ is €1.72, compared to a current price of €0.97 — trading 43.6% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Maternus-Kliniken AG's overall GF Score™ is 41/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Maternus-Kliniken AG (HAM:MAK), the current Forward Dividend Yield % is 0.00% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Maternus-Kliniken AG (HAM:MAK) Overvalued in 2026?

Based on GuruFocus' analysis, Maternus-Kliniken AG stock appears to be undervalued. The current stock price of €0.97 is trading 43.6% below its estimated GF Value™ of €1.72. GuruFocus considers Maternus-Kliniken AG to be Possible Value Trap.

Key valuation signals for HAM:MAK:

  • Forward Dividend Yield %: 0.00%
  • GF Value™: €1.72 vs. price of €0.97 (43.6% below fair value)
  • GF Score™: 41/100 with 4 warning signs

No single metric tells the full story. See the HAM:MAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Maternus-Kliniken AG Business Description

Other Exchanges 0N2K:UKMAK:Germany
Address Strasse 53 - 55, Berlin, DEU, 10117
Maternus-Kliniken AG operates as a German healthcare company focused on senior housing, care facilities, and rehabilitation clinics.
41GF Score

Get the complete analysis for HAM:MAK

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.97
Price
€1.72
GF Value